| ID | 2097 |
| No | 2097 |
| Brand Name | OSSIFIX |
| Ingredients | CALCIUM CARBONATE USP 1.250 MG EQ.TO ELEMENTAL CALCIUM 500 MG, MAGNESIUM OXIDE USP 50 MG, VITAMINE D3 BP 250 IU, ZINC SULPHATE MONOHYDRATE USP 35 MG, LYSINE HYDROCHLORIDE USP 100MG |
| Dosage Form | FILM COATED TABLET |
| Primary Packaging | ALU-PVC BLISTERPACK |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 10 X 1 X 10'S |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | PREDIALYSIS PATIENTS: IN THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM AND RESULANT METABOLIC BONE DISEASE IN PATIENTS WITH MODERATE TO SEVERE CHRONIC RENALFAILURE NOT YET ON DIALYSIS. DIALYSIS PATIENTS: FOR MANAGEMENT OF HYPOCALCEMIA AND THE RESULTANT METABOLIC BONE DISEASE IN PATIENTS UNDERGOING CHRONIC RENAL DIALYSIS |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | RED COLOUR OBLONG BICONVEX SHAPED FILM COATED TABLET. ONE SIDE PLAIN AND OTHER SIDE SCORED |
| Note | |
| License Owner | PALAMY PHARMA CO., LTD |
| Manufacturer | ZEE LABOBORATORIES |
| Country | INDIA |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 02 I 2732/06 |
| FDD Registration Date | 07/02/2024 |
| Expiry Date | 06/02/2027 |